My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 659

    1.

    Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.

    Nóvoa FJ, Boronat M, Saavedra P, Díaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A.

    Diabetes Care. 2005 Oct;28(10):2388-93.PMID: 16186268 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

    Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

    Diabetes. 2004 Jun;53(6):1549-55.PMID: 15161760 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.

    Lim SC, Tai ES, Tan BY, Chew SK, Tan CE.

    Diabetes Care. 2000 Mar;23(3):278-82.PMID: 10868851 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Diabetes Care. 2003 Mar;26(3):868-74.PMID: 12610051 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.

    Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, Chi ZN, Zhang Y, Li XY, Wang WQ, Ning G.

    Diabet Med. 2008 Jan;25(1):73-9.PMID: 18199133 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

    Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

    Diabet Med. 2004 Jul;21(7):730-7.PMID: 15209766 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging.

    Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM.

    Diabetes. 2004 Aug;53(8):2095-100.PMID: 15277391 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT.

    Abdul-Ghani MA, Sabbah M, Kher J, Minuchin O, Vardi P, Raz I.

    Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):126-30.PMID: 16187399 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

    Unwin N, Shaw J, Zimmet P, Alberti KG.

    Diabet Med. 2002 Sep;19(9):708-23. Review.PMID: 12207806 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.

    Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K.

    Hypertens Res. 2008 Jul;31(7):1357-63.PMID: 18957806 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.

    Park KS, Park YJ, Kim SW, Shin CS, Park DJ, Koh JJ, Kim SY, Kim NK, Lee HK.

    Korean J Intern Med. 2000 Jan;15(1):37-41.PMID: 10714090 [PubMed - indexed for MEDLINE]Related articles

    13.

    Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Ethn Dis. 2002 Fall;12(4):S3-10-7.PMID: 12477148 [PubMed - indexed for MEDLINE]Related articles

    14.

    [The relation between fasting plasma glucose concentrations and insulin resistance]

    Li L, Wang GX, Li P, Shang XJ, Liu C, Wang YJ, Yue GY.

    Zhonghua Nei Ke Za Zhi. 2005 Oct;44(10):755-8. Chinese. PMID: 16255885 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

    Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA.

    Diabetes. 2006 May;55(5):1430-5.PMID: 16644701 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

    Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC.

    Diabetes. 2000 Jun;49(6):975-80.PMID: 10866050 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

    Weyer C, Bogardus C, Pratley RE.

    Diabetes. 1999 Nov;48(11):2197-203.PMID: 10535454 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).

    Muntner P, He J, Chen J, Fonseca V, Whelton PK.

    Ann Epidemiol. 2004 Oct;14(9):686-95.PMID: 15380800 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.

    Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM.

    Diabetes Care. 2007 Feb;30(2):325-31.PMID: 17259502 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

    Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

    J Clin Lab Anal. 2007;21(2):85-90.PMID: 17385686 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity